Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

RPR research group prepares new cell adhesion inhibitors especially useful in asthma

June 17, 1999

FDA grants orphan drug designation to PPL's AAT for congenital deficiency

June 16, 1999

Schering-Plough prepares potent H3 antagonists for allergy, CNS disorders, etc.

June 16, 1999

Chemokine peptides designed at NeoRx useful for inflammatory disorders

June 15, 1999

Antiallergic phenothiazines patented by Eisai investigators

June 15, 1999

Array BioPharma designs series of potent and selective tryptase inhibitors

June 14, 1999

Effects of macrolide antibiotics on IL-8 release by eosinophils in asthma

June 14, 1999

Amgen reveals potent and selective typtase-inhibitory series

June 11, 1999

Cystic Fibrosis Foundation awards research grant to Genzyme

June 10, 1999

FDA says 3M's inhaled corticosteroid in CFC-free inhaler approvable for asthma

June 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...